Nikola에 대한 매도 수량은 투자자에게 Nikola의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Nikola (OTC:NKLAQ) 주식, 공매도 수량 보고

Nikola Corp is a technology innovator and integrator, working to develop inventive energy and transportation solutions. It works on a business model that enables customers and fleets to integrate next-generation truck technology, hydrogen fueling and charging infrastructure, and related maintenance. It operates in two business units: Truck and Energy. The Truck business unit and Energy business unit. The Truck business unit is engaged manufacturing and selling FCEV and BEV trucks that provide, environmentally friendly, cost effective solutions to the trucking sector. The Energy business unit is engaged in developing and constructing a network of hydrogen fueling stations to meet hydrogen fuel demand for the Company's customers.

Nikola Corp

IONQ Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>) is getting a much-needed boost, surging over 11% at one point on Monday after announcing a major quantum computing milestone. 
The company's flagship IonQ Forte Enterprise is now available globally via Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Braket and the IonQ Quantum Cloud, giving businesses and researchers access to <a href="https://www.benzinga.com/topic/quantum-computing">advanced quantum capabilities</a>.
But with shares still down more than 40% year to date, is this the spark IonQ stock needs to shake off its bearish grip?
Read Also: <a href="https://www.benzinga.com/25/03/44433571/jensen-huang-admits-mistake-says-i-was-wrong-about-quantum-computing-at-gtc-apology-fails-to-lift-rigetti-ionq-d-wave-qubt">Jensen Huang Admits Mistake, Says &#8216;I Was Wrong&#8217; About Quantum Computing: Apology Fails To Lift RGTI, IONQ, QBTS, QUBT</a>
<h1 class="wp-block-heading">Quantum Leap Or Dead Cat Bounce?</h1>
IonQ's stock has been deep in the red for 2024, but the Amazon partnership injected some optimism. Forte Enterprise's integration with Amazon Braket — a fully managed quantum service on Amazon Web Services — opens up new opportunities for industries such as life sciences, finance and manufacturing to leverage quantum power.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0401"><img loading="lazy" decoding="async" width="631" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01115933/Screenshot-2025-04-01-at-7.06.21-PM.png" alt="" class="wp-image-851598" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01115933/Screenshot-2025-04-01-at-7.06.21-PM.png 631w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/01115933/Screenshot-2025-04-01-at-7.06.21-PM-300x232.png 300w" sizes="(max-width: 631px) 100vw, 631px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0401" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
While the long-term potential is promising, the technicals tell a different story. IonQ stock at $22.92 sits below its eight-day and 50-day simple moving averages, reinforcing a strongly bearish trend. The Moving Average Convergence Divergence (MACD) indicator at a negative 1.70 also signals weakness, while the Relative Strength Index (RSI) at 43.51 suggests the stock is nearing oversold territory.
The lone bright spot? The 200-day simple moving average at 20.69, which offers a bullish signal.
<h1 class="wp-block-heading">Betting On The Quantum Future</h1>
IonQ has made headlines before with bold advancements in quantum computing, but the stock has struggled to keep up. With this latest milestone, the company is proving its tech is serious, but investors remain cautious.
While the Amazon partnership is a big step forward, IonQ still faces an uphill battle winning over Wall Street. The stock's ability to break out of its bearish cycle will depend on whether this quantum momentum translates into real-world revenue growth.
For now, IonQ bulls have something to hold onto, but skeptics are still waiting for proof that this rally is more than just a short-lived quantum fluctuation.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44582813/whats-going-on-with-ionq-stock-today">What&#8217;s Going On With IonQ Stock Today?</a></li>
</ul>
Photo: Courtesy IonQ

Technicals

Movers

Tech

Trading Ideas

AMZN

IONQ

IonQ Jumps On Amazon News, But Can It Defy Quantum Bearish Trend?

News

WNS Holdings Is Exploring A Sale After Receiving Takeover Interest From Potential Buyers Including Capgemini

B. Riley Securities analyst Lucas Pipes maintains Hallador Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNRG#NASDAQ">HNRG</a>) with a Buy and raises the price target from $13 to $15.

Price Target

Analyst Ratings

HNRG

B. Riley Securities Maintains Buy on Hallador Energy, Raises Price Target to $15

Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) shares are down 9% over the last month, but WestPark Capital analyst Curtis Shauger sees a buying opportunity in the<a href="https://www.benzinga.com/analyst-ratings/initiation/25/04/44582231/this-amazon-com-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-tuesday"> stock's recent pullback.&nbsp;</a>
Expert Ideas: Shauger initiated coverage on Amazon stock with a Buy rating and $280 price target based on the company's dominance in e-commerce and Amazon Web Services' top position in the "infrastructure as a service" market.&nbsp;
The firm estimates Amazon's general merchandise value to be nearly $1.3 trillion in 2024, nearly four times the size of Shopify's and 13 times the size of Walmart's GMV.&nbsp;
Read Next:<a href="https://www.benzinga.com/government/regulations/25/03/44517885/trump-slaps-25-tariffs-on-autos-what-it-means-for-your-next-car-purchase"> Trump Slaps 25% Tariffs On Autos: What It Means For Your Next Car Purchase</a>&nbsp;
Shauger also pointed to AWS revenue growth of 20% in 2024 and 36% EBIT margins as top of the class in the IAAS market. WestPark estimates AWS is nearly double the size of Microsoft's Azure and nearly triple the size of Alphabet's Google Cloud Platform.&nbsp;
Amazon's recent pullback offers a "unique opportunity" as the stock now trades at valuation multiples near all-time lows, approximately 12 times EBITDA basis, the analyst said. 
Shauger sees the multiple improving with continued improvement in e-commerce margins, moderation in capital expenditures or an improvement in growth.&nbsp;
The firm's $280 price target is based on a 15 times multiple and an EBITDA estimate of $205 billion.&nbsp;
"We believe AMZN will trade up to the mid point of its recent historical range as the inherent profitability of its model continues to show through," Shauger said.&nbsp;
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/03/44575292/trump-to-target-dirty-15-countries-with-tariffs-which-countries-could-be-included">Trump To Target &#8216;Dirty 15&#8217; Countries With Tariffs: Which Countries Could Be Included?</a>&nbsp;</li>
</ul>
Image: Shutterstock

Large Cap

Initiation

Amazon Stock's Recent Pullback Offers 'Unique Opportunity': Analyst

Craig-Hallum analyst Eric Stine initiates coverage on Centrus Energy (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LEU#AMEX">LEU</a>) with a Buy rating and announces Price Target of $129.

Craig-Hallum Initiates Coverage On Centrus Energy with Buy Rating, Announces Price Target of $129

UnitedHealth Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) short percent of float has risen 17.89% since its last report. The company recently reported that it has 10.25 million shares sold short, which is 1.12% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.26 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>UnitedHealth Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743527727_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for UnitedHealth Group has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing UnitedHealth Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, UnitedHealth Group's peer group average for short interest as a percentage of float is 5.17%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Peering Into UnitedHealth Group's Recent Short Interest

Trip.com Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NYSE">TCOM</a>) short percent of float has risen 13.33% since its last report. The company recently reported that it has 14.00 million shares sold short, which is 2.21% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.76 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Trip.com Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743527721_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Trip.com Group has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Trip.com Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Trip.com Group's peer group average for short interest as a percentage of float is 7.40%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

TCOM

Looking Into Trip.com Group's Recent Short Interest

FactSet Research Systems's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) short percent of float has fallen 13.73% since its last report. The company recently reported that it has 1.41 million shares sold short, which is 4.21% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.21 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>FactSet Research Systems Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743527716_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for FactSet Research Systems has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing FactSet Research Systems's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, FactSet Research Systems's peer group average for short interest as a percentage of float is 3.35%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is the Market Bullish or Bearish on FactSet Research Systems?

Morgan Stanley analyst Simon Flannery downgrades SBA Comms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBAC#NASDAQ">SBAC</a>) from Overweight to Equal-Weight and lowers the price target from $252 to $240.

Downgrades

SBAC

Morgan Stanley Downgrades SBA Comms to Equal-Weight, Lowers Price Target to $240

Morgan Stanley analyst Ronald Kamdem maintains Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a Equal-Weight and lowers the price target from $20 to $19.

Morgan Stanley Maintains Equal-Weight on Macerich, Lowers Price Target to $19

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Hims To Sell Lilly's Zepbound Through Telehealth Platform

Morgan Stanley analyst Ronald Kamdem maintains Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) with a Overweight and lowers the price target from $80 to $75.

LINE

Morgan Stanley Maintains Overweight on Lineage, Lowers Price Target to $75

Morgan Stanley analyst Dara Mohsenian upgrades Keurig Dr Pepper (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>) from Equal-Weight to Overweight and raises the price target from $38 to $40.

Upgrades

Morgan Stanley Upgrades Keurig Dr Pepper to Overweight, Raises Price Target to $40

Needham analyst Joshua Reilly reiterated a <a target="_blank" href="https://www.benzinga.com/quote/TTGT/analyst-ratings" rel="noreferrer noopener">Buy rating</a> on the shares of TechTarget Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTGT#NASDAQ">TTGT</a>) and lowered the price forecast from $40.00 to $25.00.
TechTarget is expected to align its FY25 guidance with consensus estimates of $512 million in revenue (3.4% adjusted Y/Y growth) and $98 million in adjusted EBITDA, said the analyst.
Management is likely to remain cautious due to potential sales and marketing downturns and macroeconomic headwinds in early 2025. Integration progress and $25 million in cost synergies will be key topics, the analyst noted.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44583601/chevron-sells-70-stake-in-east-texas-gas-assets-for-525m" rel="noreferrer noopener">Chevron Divests 70% Stake In East Texas Gas Assets: Details</a>
TechTarget is expected to report an in-line fourth-quarter, though management has not updated guidance to reflect one month of revenue from Informa Tech following the December 2nd merger.
Consensus revenue estimates of $78.5 million appear accurate, with Informa Tech contributing about $20 million.
Investors are likely focused on the timing of $25 million in cost synergies and the progress of Informa Tech&#8217;s integration.
They also seek clarity on how business segments will be structured. A new revenue segmentation may combine Brand &amp; Content with Intent &amp; Demand, while Intelligence &amp; Advisory could be reported separately, aligning with the updated investor presentation, opined the analyst.
TechTarget provides a unique B2B purchase intent marketing platform, leveraging first-party, privacy-compliant data from 150+ online properties.
Growth drivers include expanding its total addressable market beyond marketing teams, increased first-party data from the BrightTALK acquisition for cross-selling, and a projected rebound in global IT spending.
The updated price forecast is based on 17x EBITDA for the combined entity using consensus FY25 estimates.
Price Action: TTGT shares traded lower by 4.12% at $14.20 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/44582695/why-is-ev-battery-tech-provider-microvast-stock-surging-today" target="_blank" rel="noreferrer noopener">Why Is EV Battery Tech Provider Microvast Stock Surging Today?</a></li>
</ul>
Image via Shutterstock.

Analyst Color

Equities

Reiteration

TTGT

TechTarget Faces Macro Challenges And Valuation Compression, Analyst Cuts Price Forecast

<h3>Gainers</h3>
<ul>
<li>Surgepays (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SURG#NASDAQ">SURG</a>) stock increased by 13.5% to $2.35 during Tuesday's regular session. The market value of their outstanding shares is at $47.9 million. </li>
<li>Moving iMage Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#AMEX">MITQ</a>) stock rose 11.98% to $0.7. The market value of their outstanding shares is at $6.9 million. </li>
<li>NIP Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIPG#NASDAQ">NIPG</a>) shares increased by 9.9% to $1.77. The market value of their outstanding shares is at $99.5 million. </li>
<li>TrueCar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUE#NASDAQ">TRUE</a>) shares rose 9.81% to $1.74. The company's market cap stands at $151.3 million. </li>
<li>NFT (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MI#AMEX">MI</a>) stock increased by 9.33% to $2.46. The company's market cap stands at $12.4 million. </li>
<li>Fluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNT#NASDAQ">FLNT</a>) stock increased by 9.28% to $2.38. The market value of their outstanding shares is at $46.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Brag House Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBH#NASDAQ">TBH</a>) shares fell 80.7% to $1.27 during Tuesday's regular session. The market value of their outstanding shares is at $13.6 million. </li>
<li>Haoxi Health Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAO#NASDAQ">HAO</a>) shares declined by 18.78% to $1.03. The market value of their outstanding shares is at $2.9 million. </li>
<li>IAC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAC#NASDAQ">IAC</a>) stock declined by 14.87% to $39.11. The market value of their outstanding shares is at $3.1 billion. </li>
<li>comScore (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCOR#NASDAQ">SCOR</a>) shares declined by 14.71% to $5.86. The market value of their outstanding shares is at $28.7 million. </li>
<li>Treasure Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGL#NASDAQ">TGL</a>) shares declined by 12.21% to $0.07. The market value of their outstanding shares is at $3.5 million. </li>
<li>WiMi Hologram Cloud (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIMI#NASDAQ">WIMI</a>) shares fell 8.5% to $0.89. The company's market cap stands at $87.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FLNT

MITQ

NIPG

SCOR

SURG

TRUE

WIMI

12 Communication Services Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Reshape Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) stock moved upwards by 488.1% to $2.12 during Tuesday's regular session. The market value of their outstanding shares is at $7.0 million. </li>
<li>bioAffinity Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIAF#NASDAQ">BIAF</a>) stock increased by 236.5% to $0.87. The market value of their outstanding shares is at $13.6 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Alaunos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCRT#NASDAQ">TCRT</a>) shares moved upwards by 55.1% to $2.28. The market value of their outstanding shares is at $3.6 million. </li>
<li>Nutex Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUTX#NASDAQ">NUTX</a>) shares moved upwards by 53.55% to $72.22. The market value of their outstanding shares is at $392.6 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Hepion Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPA#NASDAQ">HEPA</a>) shares moved upwards by 39.56% to $0.6. </li>
<li>cbdMD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) stock moved upwards by 37.91% to $0.32. The company's market cap stands at $1.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Reviva Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVPH#NASDAQ">RVPH</a>) shares declined by 32.3% to $0.65 during Tuesday's regular session. The market value of their outstanding shares is at $30.0 million. The company's, Q4 earnings came out yesterday. </li>
<li>Universe Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPC#NASDAQ">UPC</a>) shares decreased by 29.88% to $2.88. The market value of their outstanding shares is at $43.7 million. </li>
<li>CARISMA Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARM#NASDAQ">CARM</a>) stock decreased by 24.23% to $0.23. The company's market cap stands at $9.8 million. </li>
<li>Corcept Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORT#NASDAQ">CORT</a>) stock declined by 18.67% to $92.9. The company's market cap stands at $9.8 billion. </li>
<li>Citius Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTXR#NASDAQ">CTXR</a>) shares decreased by 18.13% to $1.22. The market value of their outstanding shares is at $10.4 million. </li>
<li>Elicio Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELTX#NASDAQ">ELTX</a>) shares declined by 17.7% to $5.07. The company's market cap stands at $80.4 million. As per the news, the Q4 earnings report came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BIAF

CARM

CORT

CTXR

ELTX

HEPA

NUTX

RSLS

RVPH

TCRT

YCBD

12 Health Care Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Microvast Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVST#NASDAQ">MVST</a>) shares moved upwards by 35.9% to $1.59 during Tuesday's regular session. The market value of their outstanding shares is at $514.9 million. The company's, Q4 earnings came out yesterday. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) stock rose 21.8% to $0.29. The market value of their outstanding shares is at $58.3 million. The company's, Q4 earnings came out yesterday. </li>
<li>INLIF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INLF#NASDAQ">INLF</a>) stock rose 21.23% to $1.77. The market value of their outstanding shares is at $25.6 million. </li>
<li>Greenland Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTEC#NASDAQ">GTEC</a>) shares moved upwards by 18.85% to $2.08. The company's market cap stands at $28.2 million. The company's, Q4 earnings came out 4 days ago. </li>
<li>Click Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIK#NASDAQ">CLIK</a>) shares increased by 16.66% to $3.15. The company's market cap stands at $46.9 million. </li>
<li>Hong Kong Pharma Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HKPD#NASDAQ">HKPD</a>) shares rose 15.53% to $1.25. The market value of their outstanding shares is at $13.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Silynxcom (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SYNX#AMEX">SYNX</a>) shares fell 43.9% to $2.03 during Tuesday's regular session. The company's market cap stands at $10.8 million. </li>
<li>Nuvve Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVVE#NASDAQ">NVVE</a>) stock fell 29.81% to $1.06. The market value of their outstanding shares is at $1.3 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Babcock &amp; Wilcox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BW#NYSE">BW</a>) stock decreased by 19.7% to $0.54. The company's market cap stands at $50.9 million. As per the news, the Q4 earnings report came out yesterday. </li>
<li>Mint (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIMI#NASDAQ">MIMI</a>) shares decreased by 17.24% to $4.34. The company's market cap stands at $99.8 million. </li>
<li>Advent Technologies Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADN#NASDAQ">ADN</a>) stock decreased by 13.67% to $3.66. The market value of their outstanding shares is at $9.6 million. </li>
<li>Lucas GC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGCL#NASDAQ">LGCL</a>) stock declined by 11.05% to $0.43. The market value of their outstanding shares is at $34.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLIK

GTEC

HKPD

INLF

LGCL

LNZA

MIMI

MVST

NVVE

SYNX

12 Industrials Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Cloudastructure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSAI#NASDAQ">CSAI</a>) shares rose 113.1% to $9.46 during Tuesday's regular session. The market value of their outstanding shares is at $146.2 million. </li>
<li>SatixFy Communications (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SATX#AMEX">SATX</a>) shares increased by 66.25% to $2.0. The company's market cap stands at $166.7 million. </li>
<li>PicoCELA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCLA#NASDAQ">PCLA</a>) shares rose 15.8% to $0.66. The market value of their outstanding shares is at $20.3 million. </li>
<li>Bridgeline Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>) stock moved upwards by 12.83% to $1.67. The market value of their outstanding shares is at $17.4 million. </li>
<li>Sonim Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONM#NASDAQ">SONM</a>) stock increased by 12.14% to $2.4. The company's market cap stands at $11.6 million. </li>
<li>Global Engine Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLE#NASDAQ">GLE</a>) shares rose 11.99% to $1.82. The market value of their outstanding shares is at $33.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cambium Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMBM#NASDAQ">CMBM</a>) stock decreased by 51.5% to $0.34 during Tuesday's regular session. The company's market cap stands at $9.6 million. </li>
<li>DatChat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DATS#NASDAQ">DATS</a>) stock declined by 18.66% to $3.14. The company's market cap stands at $13.2 million. </li>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) shares declined by 13.12% to $1.59. The market value of their outstanding shares is at $10.5 million. </li>
<li>Pony AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) shares decreased by 13.04% to $7.67. The market value of their outstanding shares is at $2.6 billion. </li>
<li>MicroAlgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) shares declined by 11.49% to $21.46. The company's market cap stands at $214.0 million. </li>
<li>Gorilla Tech Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRRR#NASDAQ">GRRR</a>) shares decreased by 11.26% to $26.27. The market value of their outstanding shares is at $485.0 million. As per the news, the FY earnings report came out yesterday. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BLIN

CMBM

CSAI

DATS

GRRR

MLGO

MOVE

PCLA

PONY

SatixFy Communications Ltd. Ordinary Share

SATX

SONM

12 Information Technology Stocks Moving In Tuesday's Intraday Session

Goldman Sachs analyst Kate McShane on Tuesday highlighted concerns over market volatility, declining consumer activity, and ongoing economic uncertainty within the auto parts retail sector, which are influencing th<a target="_blank" href="https://www.benzinga.com/markets" rel="noreferrer noopener">e overall outlook on a few major players in the niche industry.</a>
As a result, the analyst adjusted ratings for Genuine Parts Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPC#NYSE">GPC</a>) and AutoZone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>).
Here are the key takeaways from the analyst:
Genuine Parts: McShane downgraded the stock from Neutral to Sell, lowering <a target="_blank" href="https://www.benzinga.com/quote/GPC/analyst-ratings" rel="noreferrer noopener">the price forecast from $133 to $114.</a>
The analyst writes that Genuine Parts is less well-positioned in the current market environment compared to peers like O&#8217;Reilly Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>) and AutoZone, mainly due to recent underperformance at its NAPA business, slowing trends in its European Automotive segment, and potential risks from its Industrial division in the face of an uncertain macro environment.
While Genuine Parts&#8217; guidance for FY25 suggests a stronger second half of the year, the analyst views this recovery as dependent on steady improvements in end-market demand, which may face downside risks, particularly if current trends continue to underperform management&#8217;s expectations.
The analyst observes that comparable trends at Genuine Parts&#8217; European Automotive business have weakened over the past year, with the potential for continued softness in the near term, raising concerns about the company&#8217;s performance in that segment going forward.
The analyst has revised the FY25 EPS estimate to $7.82, down from $7.94, reflecting a more cautious outlook for the second half of the year in terms of both sales and margins.
Additionally, the FY26 and FY27 EPS estimates have been lowered to $8.60 (from $9.09) and $9.55 (from $10.06), indicating ongoing concerns about future performance.
GPC shares are trading lower by 0.81% to $118.18 at last check Tuesday.
Also Read:<a target="_blank" href="https://www.benzinga.com/general/biotech/25/04/44588362/why-is-nano-cap-gri-bio-stock-skyrocketing-on-tuesday" rel="noreferrer noopener"> Why Is Nano Cap GRI Bio Stock Skyrocketing On Tuesday?</a>
AutoZone: McShane upgraded AutoZone from Sell to Neutral, <a target="_blank" href="https://www.benzinga.com/quote/AZO/analyst-ratings" rel="noreferrer noopener">raising the price forecast from $3,044 to $3,811.</a>
The analyst has upgraded the stock, citing the company&#8217;s defensively positioned business, which appears increasingly attractive in the current macroeconomic environment.
Per McShane, key factors include improvements in AutoZone&#8217;s &#8220;do it for me,&#8221; or DIFM business, a recovery in DIY trends, and the auto parts industry&#8217;s strong pricing power, which should help offset any potential tariff impacts.
Since being added to the Americas Sell list on October 14, 2024, AutoZone&#8217;s shares have risen 19.6%, outperforming the S&amp;P 500, which declined by 4.8%.
The analyst acknowledges that trends in AutoZone&#8217;s domestic business have improved, contrary to their previous view, with the company gaining market share and seeing resilient demand, particularly from its DIY customer base.
Meanwhile, the analyst also notes that AutoZone&#8217;s current valuation, based on its NTM EV/EBITDA, is above historical levels, indicating that investors are placing greater value on the company&#8217;s defensive positioning amid current market uncertainty.
The analyst has increased the FY25 EPS estimate to $148.36, up from $146.65, driven by slightly stronger domestic same-store sales growth and revised tax rate assumptions.
AZO shares are trading lower by 0.03% to $3,811.74 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44584401/whats-going-on-with-kroger-stock-today" target="_blank" rel="noreferrer noopener">What's Going On With Kroger Stock Today?</a></li>
</ul>
Image via Shutterstock.

Markets

General

ORLY

Goldman Sachs Shakes Up Auto Parts Stocks: Downgrades Genuine Parts, Upgrades AutoZone Amid Economic Volatility

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Tuesday.
The Dow traded up 0.26% to 42,110.35 while the NASDAQ rose 1.06% to 17,481.99. The S&amp;P 500 also rose, gaining, 0.59% to 5,644.98.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/44582683/top-3-tech-and-telecom-stocks-that-may-keep-you-up-at-night-in-q2">Top 3 Tech And Telecom Stocks That May Keep You Up At Night In Q2</a>
Leading and Lagging Sectors Consumer discretionary shares rose by 0.2% on Tuesday.
In trading on Tuesday, health care shares tumbled by 1.2%.
Top Headline
U.S. construction spending increased 0.7% month-over-month in February following a revised 0.5% fall in January.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>bioAffinity Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIAF#NASDAQ">BIAF</a>) shares shot up 260% to $0.9349 following a year-over-year increase in FY24 financial results.</li>
<li>Shares of Microvast Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVST#NASDAQ">MVST</a>)got a boost, surging 24% to $1.4450 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>PVH Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) shares were also up, gaining 17% to $75.60 following a fourth-quarter adjusted EPS and revenue beat. Additionally, the company announced plans to enter into a $500 million accelerated share repurchase program</li>
</ul>
Equities Trading DOWN
<ul>
<li>Aptose Biosciences Inc. &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APTO#NASDAQ">APTO</a>) shares dropped 54% to $1.45 after the company announced it is going to delist from the Nasdaq.</li>
<li>Shares of Cambium Networks Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMBM#NASDAQ">CMBM</a>) were down 52% to $0.3354 after the company announced that it will delay Form 10-K filing for fiscal year 2024.</li>
<li>Open Lending Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPRO#NASDAQ">LPRO</a>) was down, falling 40% to $1.6496 after the company announced weak quarterly results.</li>
</ul>
Commodities In commodity news, oil traded down 0.1% to $71.38 while gold traded up 0.2% at $3,155.50.
Silver traded down 0.6% to $34.41 on Tuesday, while copper fell 0.2% to $5.0230.
Euro zone
European shares were higher today. The eurozone's STOXX 600 jumped 0.46%, Germany's DAX 40 rose 0.79% and France's CAC 40 climbed 0.45%. Spain's IBEX 35 Index climbed 0.69%, while London's FTSE 100 rose 0.09%.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 gaining 0.02%, China's Shanghai Composite Index gaining 0.38%, Hong Kong's Hang Seng Index rising 0.38% and India's BSE Sensex dipping 1.80%.
Economics
<ul>
<li>The S&amp;P Global US manufacturing PMI came in at 50.2 for March, versus the preliminary reading of 49.8.</li>
<li>The ISM manufacturing PMI declined to 49 in March compared to a reading of 50.3 in February, and also missing market estimates of 49.5.</li>
<li>U.S. construction spending increased 0.7% month-over-month in February following a revised 0.5% fall in January.</li>
<li>The number of job openings fell by 194,000 to 7.568 million in February compared to a revised 7.762 million in the previous month.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/44583174/how-to-earn-500-a-month-from-unifirst-stock-ahead-of-q2-earnings">How To Earn $500 A Month From UniFirst Stock Ahead Of Q2 Earnings</a> </li>
</ul>
Photo via Shutterstock

Comments

Nikola

매도 수량

Nikola (OTC:NKLAQ) 주식, 공매도 수량 보고

뉴스

파트너 / 기고자

벤징가 글로벌